Transparency - NHS approves first non-hormonal hot flush drug

Transparency

NHS approves first non-hormonal hot flush drug

Reliability

Corroborated

Based on 9 sources

Source Diversity

Major Media (9)

Sources (9)

13 claims

5 questions

What are the specific results of the ongoing clinical trials of fezolinetant in breast cancer patients?

When will fezolinetant be available on the NHS for breast cancer patients?

What is the exact cost of fezolinetant and how does it compare to HRT?

What are the long-term side effects of fezolinetant?

How many women in the UK are currently prescribed fezolinetant?

sensitive_data

Allvarlig sjukdom

y increase the risk of breast cancer. Women who do not take HRT du

sensitive_data

Allvarlig sjukdom

bed the drug. However, breast cancer patients who go through medic

sensitive_data

Allvarlig sjukdom

London, described how breast cancer treatments can cause a rapid

sensitive_data

Allvarlig sjukdom

still being tested on breast cancer patients, and they must wait

This article was produced by Reed News using AI. All claims are cross-referenced against multiple sources.